BPC-157 and the Revised Theory of Gut Cytoprotection: Beyond Robert's Original Concept

BPC-157's unique cytoprotective properties expand Robert's classical cytoprotection concept, demonstrating prostaglandin-independent protection and adaptive cytoprotection against both exogenous and endogenous irritants.

Sikiric, Predrag et al.·Current pharmaceutical design·2010·
RPEP-016942010RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Not classified
Evidence
Not graded
Sample
Not reported

What This Study Found

BPC-157's unique cytoprotective properties expand Robert's classical cytoprotection concept, demonstrating prostaglandin-independent protection and adaptive cytoprotection against both exogenous and endogenous irritants.

Key Numbers

How They Did This

research study.

Why This Research Matters

Relevant for peptide research.

The Bigger Picture

Advances peptide research.

What This Study Doesn't Tell Us

See abstract.

Questions This Raises

  • ?Further research needed.

Trust & Context

Key Stat:
Key finding BPC-157's unique cytoprotective properties expand Robert's classical cytoprotection concept, demonstrating prostaglandin-independent protection and ad
Evidence Grade:
emerging evidence.
Study Age:
Published in 2010.
Original Title:
Revised Robert's cytoprotection and adaptive cytoprotection and stable gastric pentadecapeptide BPC 157. Possible significance and implications for novel mediator.
Published In:
Current pharmaceutical design, 16(10), 1224-34 (2010)
Database ID:
RPEP-01694

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Frequently Asked Questions

What was studied?

BPC-157 and the Revised Theory of Gut Cytoprotection: Beyond Robert's Original Concept

What was found?

BPC-157's unique cytoprotective properties expand Robert's classical cytoprotection concept, demonstrating prostaglandin-independent protection and adaptive cytoprotection against both exogenous and endogenous irritants.

Read More on RethinkPeptides

Related articles coming soon.

Cite This Study

RPEP-01694·https://rethinkpeptides.com/research/RPEP-01694

APA

Sikiric, Predrag; Seiwerth, Sven; Brcic, Luka; Sever, Marko; Klicek, Robert; Radic, Bozo; Drmic, Domagoj; Ilic, Spomenko; Kolenc, Danijela. (2010). Revised Robert's cytoprotection and adaptive cytoprotection and stable gastric pentadecapeptide BPC 157. Possible significance and implications for novel mediator.. Current pharmaceutical design, 16(10), 1224-34.

MLA

Sikiric, Predrag, et al. "Revised Robert's cytoprotection and adaptive cytoprotection and stable gastric pentadecapeptide BPC 157. Possible significance and implications for novel mediator.." Current pharmaceutical design, 2010.

RethinkPeptides

RethinkPeptides Research Database. "Revised Robert's cytoprotection and adaptive cytoprotection ..." RPEP-01694. Retrieved from https://rethinkpeptides.com/research/sikiric-2010-revised-roberts-cytoprotection-and

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.